SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

BriaCell Therapeutics Corp.
Date: July 15, 2025 · CIK: 0001610820 · Accession: 0001641172-25-019658

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-288562

Date
July 15, 2025
Author
LLC
Form
CORRESP
Company
BriaCell Therapeutics Corp.

Letter

ThinkEquity LLC

State Street, 41 st Floor

New York, NY 10004

July 15, 2025

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street NE

Washington, D.C. 20549

Attention: Alan Campbell

Re: BriaCell Therapeutics Corp. (the "Company")

Registration Statement on Form S-1 (the "Registration Statement")

File No. 333-288562

Ladies and Gentlemen:

ThinkEquity LLC ("ThinkEquity") hereby concurs in the request by the Company to withdraw its request for an accelerated effective date of the above-referenced Registration Statement to 5:00 p.m. Eastern Time on July 15, 2025, or as soon as practicable thereafter.

In addition, ThinkEquity, solely acting as placement agent on a best efforts basis in an offering pursuant to the Registration Statement, hereby concurs in the request by the Company that the effective date of the above-referenced Registration Statement be accelerated to 1:00 p.m. Eastern Time on July 15, 2025, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time pursuant to Rule 461 under the Securities Act of 1933 (the "Securities Act").

ThinkEquity affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

Very
truly yours,
ThinkEquity
LLC

Show Raw Text
CORRESP
 1
 filename1.htm

 ThinkEquity
LLC

 17
State Street, 41 st Floor

 New
York, NY 10004

 July
15, 2025

 VIA
EDGAR

 U.S.
Securities and Exchange Commission

 Division
of Corporation Finance

 100
F Street NE

 Washington,
D.C. 20549

 Attention:
Alan Campbell

 Re:
 BriaCell
 Therapeutics Corp. (the "Company")

 Registration
 Statement on Form S-1 (the "Registration Statement")

 File
 No. 333-288562

 Ladies
and Gentlemen:

 ThinkEquity
LLC ("ThinkEquity") hereby concurs in the request by the Company to withdraw its request for an accelerated effective date
of the above-referenced Registration Statement to 5:00 p.m. Eastern Time on July 15, 2025, or as soon as practicable thereafter.

 In
addition, ThinkEquity, solely acting as placement agent on a best efforts basis in an offering pursuant to the Registration Statement,
hereby concurs in the request by the Company that the effective date of the above-referenced Registration Statement be accelerated to
1:00 p.m. Eastern Time on July 15, 2025, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such
time pursuant to Rule 461 under the Securities Act of 1933 (the "Securities Act").

 ThinkEquity
affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration
Statement.

 Very
 truly yours,

 ThinkEquity
 LLC

 /s/
Eric Lord

 Eric
 Lord

 Head
 of Investment Banking